"Małopolskie Badania Kliniczne to specjalistyczne ośrodki medyczne zajmujące się prowadzeniem badań klinicznych na terenie Małopolski. Dodatkowo w naszym Centrum Medycznym czekają na Państwa wysokiej klasy specjaliści w dziedzinach: reumatologii: dr Iwona Hajdyła-Banaś, dr Elżbieta Marciszewska, dr Małgorzata Sobczyk dr Katarzyna Ząber, dr n. med. Piotr Krawiec, prof. Zbigniew Żuber; gastrologii: dr Zbigniew Wylegała; nefrologii: prof. Katarzyna Krzanowska; kardiologii: dr Marcin Waligóra; radiologii: dr Jakub Pieła, prof. Wadim Wojciechowski. Ponadto istnieje możliwość wykonania badań USG. Rejestracja telefoniczna wizyt od poniedziałku do piątku od 15:00 do 20:00."

During the past decade, Malopolskie Badania Kliniczne Sp. z o.o. Sp. k. conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Malopolskie Badania Kliniczne Sp. z o.o. Sp. k." #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Mannkind Corporation" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Malopolskie Badania Kliniczne Sp. z o.o. Sp. k." #1 collaborator was "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Malopolskie Badania Kliniczne Sp. z o.o. Sp. k." are "Arthritis, Psoriatic" (2 trials), "Active Psoriatic Arthritis" (1 trials), "Asthma" (1 trials), "Diabetes Mellitus, Type 1" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Malopolskie Badania Kliniczne Sp. z o.o. Sp. k." in a lesser frequency.

Most popular intervention types in "Malopolskie Badania Kliniczne Sp. z o.o. Sp. k." are "Drug" (10 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Guselkumab" (2 trials), "Nipocalimab" (2 trials), "Adalimumab" (1 trials) and "BMS-986165 Dose A" (1 trials). Other intervention names were less common.

The vast majority of trials in "Malopolskie Badania Kliniczne Sp. z o.o. Sp. k." are 10 trials for "All" genders.

Currently, there are NaN active trials in "Malopolskie Badania Kliniczne Sp. z o.o. Sp. k.". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Malopolskie Badania Kliniczne Sp. z o.o. Sp. k., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Malopolskie Badania Kliniczne Sp. z o.o. Sp. k., 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".